SCHEMBL22474564

SCHEMBL22474564

Cc1nccc2c3cc(Cl)cc(-c4cnccc4Cl)c3n(CC3CC3)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 6/20 0.37
DYRK1A Q13627 4/20 0.35
KCNH2 Q12809 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CYP17A1 P05093 2/20 0.34
ROCK2 O75116 1/20 0.34
BRD4 O60885 1/20 0.33
BRD2 P25440 1/20 0.33
BRD3 Q15059 1/20 0.33
BRDT Q58F21 1/20 0.33
ACHE P22303 1/20 0.32
HASPIN Q8TF76 1/20 0.32
DYRK2 Q92630 1/20 0.32
MAOA P21397 1/20 0.32
CRHR2 Q13324 3/20 0.32
KDM4C Q9H3R0 1/20 0.32
CCNT1 O60563 1/20 0.32
CDK9 P50750 1/20 0.32
CHUK O15111 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30664216 1.00 CRHR1 (0.37) CRHR1DYRK1AKCNH2HDAC1HDAC6
SCHEMBL20123040 0.89 CYP17A1 (0.35) DYRK1ACYP17A1ACHEHASPINDYRK2
SCHEMBL30664207 0.85 CRHR1 (0.42) CRHR1
SCHEMBL20122950 0.85 CRHR1 (0.42) CRHR1
SCHEMBL30664292 0.84 BRD4 (0.37) CRHR1DYRK1AKCNH2HDAC1HDAC6
SCHEMBL20122937 0.84 BRD4 (0.37) CRHR1DYRK1AKCNH2HDAC1HDAC6
SCHEMBL20123041 0.82 BCL6 (0.35) CRHR1DYRK1AHDAC1HDAC6ACHE
SCHEMBL30664241 0.82 BCL6 (0.35) CRHR1DYRK1AHDAC1HDAC6ACHE
SCHEMBL20123079 0.82 HDAC1 (0.35) CRHR1DYRK1AHDAC1HDAC6ACHE
SCHEMBL30664229 0.82 HDAC1 (0.35) CRHR1DYRK1AHDAC1HDAC6ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2021-09-28 US disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 CRHR1 908/4885DYRK1A 493/4885KCNH2 3028/4885
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 CRHR1 908/4885DYRK1A 493/4885KCNH2 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.